Bibliography Updates May 2020
Myriad RBM’s biomarker testing services and TruCulture product have been cited in over 1000 peer-reviewed research articles. As a CLIA-certified labo...
Networks of blood proteins in the neuroimmunology of schizophrenia
Clark D. Jeffries, Diana O. Perkins, Margot Fournier, Kim Q. Do, Michel Cuenod, Ines Khadimallah, Enrico Domenici, Jean Addington, Carrie E. Bearden,...
Myriad RBM’s DiscoveryMAP® Identifies a Protein Biomarker Panel for Bipolar Disorder
Researchers at the Mayo Clinic used Myriad RBM’s Multi-Analyte Profile (MAP) platform to analyze 320 serum proteins in healthy control subjects and su...
Blood-based proteins are crucial to the development of biomarker tests aimed at improving the diagnosis and treatment of psychiatric disorders
A recent review of studies measuring proteins in blood serum/plasma illustrates the systemic nature of disease-related changes in patients with schizo...
Vitamin D Binding Protein in serum demonstrates utility as a biomarker of Alzheimer’s disease
Researchers at the University of Texas Health Science Center, San Antonio used a Multiple Indicators Multiple Causes (MIMIC) approach to evaluate the...
Blood-based proteins help elucidate mediators of cognitive impairment in Late Life Depression (LLD)
Researchers from the University of Pittsburgh analyzed 242 proteins in conjunction with structural brain abnormalities to identify biological mechanis...
Inflammatory Proteins Hold Promise as Early Predictors of Psychosis
Researchers at Johns Hopkins University published data suggesting that a panel of inflammatory proteins measured in blood may be useful in identifying...